Clotting Disorder: Clinical Trials

5 trials for Clotting Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated, 1 withdrawn. 2 Phase 4, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Withdrawn 1
Early Phase 11Terminated 1

Follow Clotting Disorder: new trials by email Literature Review of Clotting Disorder trials Research Report on Clotting Disorder

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
BVA-200 vs BVA-100 Validation Study
BVA-200 - Heart Failure, High Blood Pressure
CompletedDaxor Corporation622023-05-232024-01-29
The Influence of Tramadol on Platelet Function
Tramadol - Drug Toxicity, Platelet Dysfunction
Phase 4CompletedMedical University of Graz332022-01-262024-01-18
Reinforcement Learning for Warfarin Dosing
Reinforcement Learning, Heath Care Provider - Clotting Disorder
Phase 4WithdrawnUniversity of Louisville2022-01-012022-03-04
Coagulation and Fibrinolysis of Estradiol in Transwomen
Estradiol Tablets, Transdermal patch - Transgenderism, Clotting Disorder
Early Phase 1TerminatedMedical College of Wisconsin62021-12-072022-12-21
Clotting Parameters After Medical Abortion
Thromboelastometry, Clotting Studies, Full Blood Count - Abortion Early, Abortion, Complete
CompletedNHS Lothian452021-03-262022-04-20

Narrower conditions

Hemostatic Disorders (5)  ·  Anemia (1)  ·  Diabetes Mellitus (1)  ·  Disease (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Heart Failure (1)  ·  Hypercholesterolemia (1)  ·  Hypertension (1)  ·  Kidney Diseases (1)  ·  Thyroid Diseases (1)  ·  Transsexualism (1)  ·  Venous Thromboembolism (1)  ·  Venous Thrombosis (1)  ·  Wounds and Injuries (1)

Broader conditions

Cardiovascular Diseases (5)  ·  Hematologic Diseases (5)  ·  Hemic and Lymphatic Diseases (5)  ·  Hemorrhagic Disorders (5)  ·  Vascular Diseases (5)  ·  Behavior (1)  ·  Chemically-Induced Disorders (1)  ·  Dyslipidemias (1)  ·  Embolism and Thrombosis (1)  ·  Endocrine System Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Glucose Metabolism Disorders (1)  ·  Heart Diseases (1)  ·  Hyperlipidemias (1)

Interventions

Blood Cell Count (1)  ·  Estradiol (1)  ·  Pregnancy Tests (1)  ·  Reinforcement Machine Learning (1)  ·  Thrombelastography (1)  ·  Tramadol (1)  ·  Transdermal Patch (1)

Sponsors

Daxor Corporation (1)  ·  Medical College of Wisconsin (1)  ·  Medical University of Graz (1)  ·  NHS Lothian (1)  ·  University of Louisville (1)

Countries

United States (2)  ·  Austria (1)  ·  United Kingdom (1)

Top investigators

Jenna Sarvaideo, DO (1)  ·  John J Reynolds-Wright, MBChB (1)  ·  Jonathan Feldschuh (1)  ·  Philipp Zoidl, MD (1)